Ads
related to: dupixent commercial- Coverage Support
Learn More About Insurance
Download Sample Letter
- Resources
Get Help With Access
Download Resources Today
- Coverage Support
Search results
Regeneron, Sanofi to seek new Dupixent approval in US after COPD success
BioPharma Dive via Yahoo Finance· 6 months agoResults from the second of two Phase 3 trials testing the blockbuster drug in the respiratory...
What This Drug News Could Mean for Sanofi Shareholders
Motley Fool· 1 year agoIn the middle of December, Sanofi's (NASDAQ: SNY) and Regeneron Pharmaceuticals' (NASDAQ: REGN)...
Sanofi Expects Moderate 2023 Profit Growth On Dupixent Demand, But Dampened By Aubagio Generics...
Benzinga via Yahoo Finance· 1 year agoSanofi SA (NASDAQ: SNY) forecasts 2023 adjusted earnings per share to grow by a "low single-digit"...
Regeneron Pharmaceuticals Inc (REGN) Reports Modest Revenue Growth Amidst Strong Dupixent Sales
GuruFocus.com via Yahoo Finance· 4 months agoRevenue Growth: Full year 2023 revenues increased by 8% to $13.12 billion, with a 14% rise excluding...
Sanofi (SNY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 month agoImage source: The Motley Fool. Sanofi (NASDAQ: SNY) Q1 2024 Earnings Call Apr 25, 2024, 8:30 a.m. ET Contents: Prepared Remarks Questions and Answers...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2022 Earnings Call Transcript (Corrected)
Insider Monkey via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2022 Earnings Call Transcript February 3, 2023...
Regeneron Pharmaceuticals Inc (REGN) Reports 15% Revenue Growth in Q3 2023
GuruFocus.com via Yahoo Finance· 7 months agoRegeneron Pharmaceuticals Inc (NASDAQ:REGN) reported a 15% increase in revenues to $3.36 billion in...
Sanofi trial failure halts work on breast cancer treatment amcenestrant
Reuters via Yahoo News· 2 years agoSanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial...
Analysis-Meagre medicine cabinet leaves Sanofi unloved
Reuters via Yahoo Finance· 2 years agoSanofi's recent stock rout underscores the pressure on the French drug maker to redouble its efforts...
Q4 2023 Regeneron Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants George D. Yancopoulos; Co-Founder, President, Chief Scientific Officer & Co-Chairman; Regeneron Pharmaceuticals, Inc. Leonard S. Schleifer; Co-Founder, President, CEO & Co-Chairman ...
Ads
related to: dupixent commercial